Healthcare

SB 925 modifies compensation and benefits for specific National Guard members. The bill aims to adjust financial support and perks they receive, though the exact changes (such as pay rates or healthcare details) aren't specified in the provided abstract. As of the latest update, the bill is under review by the Senate Veterans and Military Affairs Committee after its first reading. Since the official abstract lacks specific provisions, this summary reflects only the bill's stated purpose and current procedural status.

The provided context does not include sufficient details about SB 1387's specific provisions, affected parties, or policy changes. The bill's title and abstract only state it "modifies provisions relating to autopsies" without describing any concrete mechanisms, affected groups, or legislative changes. Without additional information on what aspects of autopsy procedures are being altered, who would be impacted, or how the changes would function, a substantive summary cannot be created. This appears to be a procedural bill requiring more specific legislative text to analyze.

SB 1664 - This act establishes the "Honest Billing Act". Under this act, each off-campus outpatient department of a health care facility, as defined in the act, shall apply for, obtain, and use a unique national provider identifier (NPI) on all claims filed after December 31, 2026, in this state for reimbursement or payment for health care services provided in that department. No facility shall submit a claim for services to a health carrier or hold an enrollee liable for such services, unless those services are billed using a separate unique NPI for the department, as described in the act. A facility that holds an enrollee liable for services billed in violation of this act shall be subject to Missouri Merchandising Practice Act enforcement by the Attorney General. A facility applying for licensure or license renewal in this state shall demonstrate its compliance with the provisions of this act as a condition of licensure. The Department of Health and Senior Services may impose specified penalties on any licensee for violating the provisions of this act. The Department of Commerce and Insurance may refer any violation of this act to the Department of Health and Senior Services. This act is substantially similar to HB 502 (2025). SARAH HASKINS

SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON

SB 1498 - This act establishes the "Cancer Patients' Bill of Rights", which includes the right to understand diagnoses and be informed about treatment options, to transparent and timely processes to contract with treatment specialists and testing, to medical treatments for pain management, and to relevant clinical trials and medical research. The Department of Health and Senior Services shall make the Cancer Patients' Bill of Rights readily available online. This act is identical to SB 263 (2025) and SB 1403 (2024). SARAH HASKINS

This bill lacks sufficient detail in the provided context to generate a substantive summary. The official abstract only states it "requires disclosure for certain products produced, sold, or distributed in Missouri" without specifying which products, what disclosure is required, or who is affected. No key mechanisms, provisions, or concrete policy changes are described in the available information. Without additional details on the scope of products, disclosure format, or implementation, a factual summary cannot be created. A proper summary would require the full bill text or more detailed legislative description.

SCS/SB 1635 - This act modifies provisions relating to state health plans. The board of the Missouri consolidated health care plan (MCHCP) shall implement any new health care benefit mandate enacted by the General Assembly, including but not limited to, requirements for the provision of specific health care services, specific diseases, or for certain health care providers. No later than July first of the year following the first full calendar year of coverage for a new health care benefit mandate and quarterly thereafter, the board of the MCHCP shall submit to the director of the Department of Commerce and Insurance a report as described in the act. No later than March first of the year following the second full calendar year of the coverage for a new health benefit mandate, the director of the Department of Commerce and Insurance shall submit to the President Pro Tem of the Senate and the Speaker of the House of Representatives a final report outlining the impact of the new health care benefit mandate on the MCHCP. Any new health care benefit mandate enacted after August 28, 2026 that requires a health carrier to provide coverage under a health benefit plan for specific health care services, specific diseases, or for certain health care providers shall only apply to the MCHCP. Coverage under MCHCP shall be effective for a period of thirty-six consecutive months and shall remain in effect until the General Assembly takes action or until the mandate sunsets in absence of legislative action. TAYLOR MIDDLETON

SB 1705 - This act requires health benefit plans issued or renewed on or after January 1, 2026, to provide coverage for certain preventative health care services without cost-sharing. Such services shall be consistent with the recommendations and guidelines of the U.S. Preventative Services Task Force, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and the Health Resources and Services Administration, and related federal rules or guidance issued as of December 31, 2025. The Director of the Department of Commerce and Insurance shall, by rule, adopt regulations to require health benefit plans to provide coverage for preventative health care services without cost-sharing requirements consistent with the recommendations and guidance of such entities issued after December 31, 2025. Additionally, this act establishes the "Health Insurance Preventative Health Care Services Advisory Committee" within the Department, which shall consist of 5 members, three of whom will represent health care providers and two of whom will represent health carriers and health benefit plans. The advisory committee shall meet at least once a year to consider any updates or modifications to the preventative health care services described in this act and shall submit a report of any recommendations to the Department, the General Assembly, and the Governor by November first each year. This act is identical to HB 3452 (2026), and substantially similar to HB 3450 (2026). TAYLOR MIDDLETON

SB 1490 - Currently, insurers shall issue payments to certain health care providers within 30 days of receipt by the insurer of all documents needed to determine the claim. This act adds athletic trainers to that list of providers. Additionally, this act adds athletic trainers to the list of practitioners covered by provisions of existing law relating to health carrier credentialing procedures. This act is identical to HB 1965 (2026) and HB 469 (2023). TAYLOR MIDDLETON

SB 1482 - This act modifies provisions relating to abuse and neglect of adult day care program participants, including modifying the definition of "abuse" to include financial exploitation, creating a definition of "neglect", requiring mandated reporting of abuse or neglect with criminal penalties for failure to report, establishing procedures for investigating reports of abuse or neglect, and establishing procedures for reporting misappropriated property or funds of adult day care program participants. This act also modifies provisions relating to abuse and neglect of elderly and disabled persons by adding financial exploitation to the definition of "abuse"; adding persons to the list of mandated reporters in current law for in-home services clients, long-term care facilities, and personal care assistance services; requiring certain investigative reports to be confidential; and permitting hearings for persons placed on employee disqualification lists to take place by telephone or electronic means. This act establishes procedures for reporting misappropriation of property or funds for patients of certain medical facilities and entities, including hospitals and home health agencies. Finally, this act makes several technical changes to the current elderly and disabled persons abuse and neglect statutes. SARAH HASKINS